Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Practical Management of Non-Scarring Alopecia and Hair Care in Skin of Color

Description

The talk focused on practical management of non-scarring alopecia and hair care in skin of color, especially highly textured hair, with an emphasis on real-world clinic questions and culturally aware counseling. It reviewed key hair care practices: less frequent shampooing, heavy use of conditioners and oils, and common styling products. The speaker stressed asking specific questions about whether hair is natural or chemically straightened, worn loose or braided, whether extensions, wigs, or glue are used, and not assuming anything by appearance alone. The lecture detailed common styling methods such as relaxers, texturizers, keratin treatments, braids, twists, weaves, crochet styles, locks, tape-ins, wigs, and lace fronts, noting that tight styles and glue can contribute to traction and breakage. She highlighted problems like trichorrhexis nodosa, seborrheic dermatitis worsened by scalp oils, and traction alopecia, and advised treating seb derm with shampoos such as ketoconazole or cyclopirox plus anti-inflammatory therapy, while being mindful of cosmetic tolerability and coverage issues. For hair loss, she emphasized that traction alopecia can become scarring if caught late, that frontal fibrosing alopecia and alopecia areata are often misdiagnosed as traction, and that multiple diagnoses commonly coexist, especially androgenetic alopecia with traction or CCCA. Management strategies included reducing tension styles, satin hair care, topical or oral minoxidil, spironolactone/finasteride/dutasteride when appropriate, intralesional triamcinolone with caution about hypopigmentation, and antibiotics if folliculitis is present. Telogen effluvium was discussed as increasingly common after COVID, GLP-1 use, surgery, weight loss, and stress, with attention to triggers, nutrition, protein intake, and labs. Alopecia areata management highlighted the importance of trichoscopy, cautious use of ILK, and the promise of FDA-approved JAK inhibitors, while noting that skin of color patients may need more time and counseling to accept newer therapies. The speaker ended by recommending patient and physician resources and mentorship opportunities.

View more

Conclusions

  • Effective care for non-scarring alopecia in skin of color depends on asking detailed questions about hair practices, because styling methods, products, and cultural routines strongly affect both diagnosis and treatment.
  • Highly textured hair generally requires less frequent shampooing and more layered conditioning, while oil should be used cautiously on the scalp because it can worsen seborrheic dermatitis even if it helps the hair shaft.
  • Clinicians should not assume hair status from appearance alone, since natural hair, relaxers, braids, locs, wigs, extensions, and glue-based styles can all create different scalp risks.
  • Tight traction from styles such as braids, weaves, wigs, and glued applications can cause traction alopecia, which may become irreversible if not recognized early.
  • Traction alopecia often coexists with other disorders such as androgenetic alopecia, alopecia areata, or frontal fibrosing alopecia, so a broad differential and low threshold for biopsy or trichoscopy are important.
  • Standard management of traction-related hair loss focuses on reducing tension, using topical or intralesional anti-inflammatory therapy, minoxidil, and treating associated folliculitis when present.
  • Seborrheic dermatitis in textured hair can often be managed with antifungal shampoos or topical agents plus anti-inflammatory therapy, with attention to cosmetically acceptable formulations and correct use.
  • Androgenetic alopecia in skin of color is commonly part of a mixed diagnosis rather than an isolated problem, and oral minoxidil with antiandrogens such as spironolactone or dutasteride/finasteride can be effective.
  • Telogen effluvium is increasingly common after stress, illness, surgery, weight change, medications, and nutritional deficiency, and management should focus on trigger reversal, nutrition, and treating any underlying AGA.
  • Alopecia areata is frequently misdiagnosed as traction or scarring alopecia in skin of color, but trichoscopy, careful examination, and awareness of pattern variants can improve accuracy.
  • The arrival of FDA-approved JAK inhibitors has transformed alopecia areata treatment, but clinicians may need to counsel cautiously because patients with skin of color may be especially risk-averse.
  • Overall, successful hair-loss care in skin of color requires culturally informed counseling, pattern recognition, early intervention, and shared decision-making rather than a one-size-fits-all approach.
  • De Souza B, Tovar-Garza A, Uwakwe LN, McMichael A. Bitemporal Scalp Hair Loss: Differential Diagnosis of Nonscarring and Scarring Conditions. J Clin Aesthet Dermatol. 2021;14(2):26-33.#10.1007/s00403-024-03485-0